These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 25959631
1. Pharmacokinetics of tenofovir during pregnancy and postpartum. Best BM, Burchett S, Li H, Stek A, Hu C, Wang J, Hawkins E, Byroads M, Watts DH, Smith E, Fletcher CV, Capparelli EV, Mirochnick M, International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) P1026s Team. HIV Med; 2015 Sep; 16(8):502-11. PubMed ID: 25959631 [Abstract] [Full Text] [Related]
8. Reduced indinavir exposure during pregnancy. Cressey TR, Best BM, Achalapong J, Stek A, Wang J, Chotivanich N, Yuthavisuthi P, Suriyachai P, Prommas S, Shapiro DE, Watts DH, Smith E, Capparelli E, Kreitchmann R, Mirochnick M, IMPAACT P1026s team. Br J Clin Pharmacol; 2013 Sep; 76(3):475-83. PubMed ID: 23305215 [Abstract] [Full Text] [Related]
10. Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women. Stek A, Best BM, Wang J, Capparelli EV, Burchett SK, Kreitchmann R, Rungruengthanakit K, Cressey TR, Mofenson LM, Smith E, Shapiro D, Mirochnick M. J Acquir Immune Defic Syndr; 2015 Sep 01; 70(1):33-41. PubMed ID: 25950206 [Abstract] [Full Text] [Related]
11. Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum. Read JS, Best BM, Stek AM, Hu C, Capparelli EV, Holland DT, Burchett SK, Smith ME, Sheeran EC, Shearer WT, Febo I, Mirochnick M. HIV Med; 2008 Nov 01; 9(10):875-82. PubMed ID: 18795962 [Abstract] [Full Text] [Related]
12. The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women. Colbers AP, Hawkins DA, Gingelmaier A, Kabeya K, Rockstroh JK, Wyen C, Weizsäcker K, Sadiq ST, Ivanovic J, Giaquinto C, Taylor GP, Moltó J, Burger DM, PANNA network. AIDS; 2013 Mar 13; 27(5):739-48. PubMed ID: 23169329 [Abstract] [Full Text] [Related]
15. Lopinavir and tenofovir interaction observed in non-pregnant adults altered during pregnancy. Mulligan N, Salama E, Momper JD, Capparelli EV, Stek A, Chakhtoura N, Mirochnick M, Best BM, IMPAACT P1026s Protocol Team. J Clin Pharm Ther; 2021 Oct 13; 46(5):1459-1464. PubMed ID: 34254323 [Abstract] [Full Text] [Related]
16. Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s. Brooks KM, Pinilla M, Stek AM, Shapiro DE, Barr E, Febo IL, Paul ME, Deville JG, George K, Knowles K, Rungruengthanakit K, Browning R, Chakhtoura N, Capparelli EV, Mirochnick M, Best BM, IMPAACT P1026s Protocol Team. J Acquir Immune Defic Syndr; 2022 Jul 01; 90(3):343-350. PubMed ID: 35195573 [Abstract] [Full Text] [Related]
17. Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants. Flynn PM, Mirochnick M, Shapiro DE, Bardeguez A, Rodman J, Robbins B, Huang S, Fiscus SA, Van Rompay KK, Rooney JF, Kearney B, Mofenson LM, Watts DH, Jean-Philippe P, Heckman B, Thorpe E, Cotter A, Purswani M, PACTG 394 Study Team. Antimicrob Agents Chemother; 2011 Dec 01; 55(12):5914-22. PubMed ID: 21896911 [Abstract] [Full Text] [Related]
18. Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum. Eke AC, McCormack SA, Best BM, Stek AM, Wang J, Kreitchmann R, Shapiro D, Smith E, Mofenson LM, Capparelli EV, Mirochnick M, IMPAACT P1026s Protocol TeamDivision of Maternal Fetal Medicine, Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.. J Clin Pharmacol; 2019 Mar 01; 59(3):386-393. PubMed ID: 30358179 [Abstract] [Full Text] [Related]